Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Join | Sign in
Home>Videos>This Video
  Videos

Return

Quality Western blot imaging is now child´s play
GE Healthcare Life Sciences

GE Healthcare Life Sciences presents ImageQuant LAS 500, a CCD camera based imager that can dramatically improve the data quality of your Westem blot protocol. ImageQuant LAS 500 places sensitive chemiluminescence detection at your fingertips, through a simple yet powerful touchscreen interface. The system covers chemiluminescent, fluorescent and colorimetric applications. ImageQuant LAS 500 can be used to image chemiluminescent Western blots, blots and gels visualized using Deep Purple Total Protein Stain, UV fluorescent DNA gels stained with SYBR Green or ethidium bromide, and gels visualized with Coomassie Blue or silver stain. And it can automatically overlay an image of the molecular weight marker associated with your Western blot.

Request more information
Company product page



For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here

Scientific News
NIH-Sponsored HIV Vaccine Trial Launches In South Africa
Early-stage trial aims to build on RV144 results.
New Class of Antibodies Raises Hope of Dengue Fever Vaccine
Scientists have discovered a new class of human antibodies against the dengue fever virus, which could be exploited to develop a vaccine.
Ebola Vaccine Trial Opens in Liberia
Study led by Liberia-NIH partnership will test two experimental vaccines.
Beating The Clock: New Treatment For Rabies Developed
University of Georgia researchers have developed a new treatment for rabies.
Utilizing Fast HPLC Screening Methods for the Detection of Steroids
Analysis of steroids improved by choosing the optimal HPLC column for the separation.
New Approach May Lead to Inhalable Vaccines
The approach using nanoparticles could lead to development of inhalable vaccines for influenza, pneumonia and tuberculosis.
New Mouse Study Method Enables Comparative Vaccine Studies for Tularemia
The study appears online in Clinical Vaccine and Immunology.
Oxford Vaccine Group Begins First Trial of New Ebola Vaccine
Oxford University doctors and scientists are starting the first safety trial of an experimental preventative Ebola vaccine regimen being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen).
UMMS Receives $6.1 M to Develop Model for Predicting Gene Expression
Insight into regulation of the genes that allow the immune system to recognize pathogens will help scientists rationally design new vaccines and prevent autoimmunity.
GRP78 Protein Possible Universal Therapeutic Target
Drug combination including Viagra is effective tool in targeting the protein.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters